CompoAtlas

DIM Enhanced

Natural health product licensed in Canada

Licence holder
Douglas Laboratories Canada
NPN or DIN-HM
80060361
Status
Inactive licence
Licence date
28 April 2015
Revision date
11 August 2015
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Camellia sinensis

Source : Camellia sinensis - feuille

Extraction ratio : 20:1

Dry plant equivalent : 4,000 mg

Potency : 95 % Polyphenols

200 mgNot calculated
Camellia sinensis

Source : Camellia sinensis - feuille

Potency : 45 % Epigallocatechin 3-gallate

Not specifiedNot calculated
3,3'-Methylenebis-1H-indole

Source : 3,3'-diindolylméthane

31.25 mgNot calculated
Wasabia japonica

Source : Rhizome

50 mgNot calculated
Curcuminoïdes

Source : Curcuminoids

25 mgNot calculated
Curcuminoïdes

Source : Curcuma longa - rhizome

25 mgNot calculated
Vitamine E

Source : d-alpha tocophérol

7.5 mg ATNot calculated
Vitamine E

Source : d-alpha tocophérol

11.25 UINot calculated

Non-medicinal ingredients

Amidon de maïs, Vitamine E, Phosphatidylcholine, Phosphate de calcium dibasique dihydraté, Hypromellose, Silice, Stéarate de magnésium, cellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsuleminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

An antioxidant for the maintenance of good health. Helps to support/promote healthy estrogen metabolism/balance. Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cylical mastalgia).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80060361

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2015. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line